Related Experiment Video
Updated: Feb 27, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Multidrug-resistant tuberculosis and leprosy: An unsolved mystery
Robin Gupta1, Kranti Garg1, Mala Bhalla2
1Department of Pulmonary Medicine, Government Medical College and Hospital, Chandigarh, India.
A rare case of multidrug-resistant tuberculosis (TB) co-occurring with leprosy is presented. This unique dual infection highlights emerging challenges in managing these ancient diseases.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Tuberculosis (TB) and leprosy are chronic infectious diseases caused by Mycobacterium species.
- Both diseases remain significant global health challenges, particularly in resource-limited settings.
- The rise of drug-resistant strains, especially in TB, complicates treatment and control efforts.
Observation:
- This report details a unique and previously undocumented case of co-infection with multidrug-resistant tuberculosis (MDR-TB) and leprosy.
- The patient presented with clinical manifestations and diagnostic challenges arising from the simultaneous presence of both infections.
- The clinical course was atypical, necessitating a re-evaluation of diagnostic and therapeutic strategies.
Findings:
- The co-occurrence of MDR-TB and leprosy represents a novel clinical scenario.
- Successful management requires careful consideration of drug interactions and resistance patterns for both pathogens.
- This case underscores the potential for complex co-infections in the context of evolving antimicrobial resistance.
Implications:
- Clinicians must be vigilant for co-infections, especially in patients with a history of or exposure to TB and leprosy.
- The findings necessitate a re-evaluation of diagnostic algorithms and treatment guidelines for patients with co-existing TB and leprosy.
- Further research is crucial to understand the epidemiology, pathogenesis, and optimal management of this rare dual infection.
More Related Videos
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...